生物科技领域近日迎来了一次重要的突破，基因编辑技术CRISPR 3.0的临床数据正式公布，引发了市场的广泛关注。这一技术的进展不仅标志着医学研究进入了一个全新的阶段，同时也为相关股票带来了显著的上涨趋势，生物科技股集体爆发成为市场热议的话题。

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $38.54, denoting a -1.76% change from the preceding trading day. Gene therapy developer CRISPR Therapeutics AG ...

153 154 Moreover, the CRISPR-Cas13a enzyme could target and edit RNA transcripts, such as RNA editing and APA,155 156 which represents new approach to targeting RNA molecules from AS with potential ...

It has been 20 years since the term “genome editing” first entered the scientific lexicon, a field that was revolutionized by the development of CRISPR gene editing in 2012. But the remarkable ...

The CRISPR system has transformed many research areas, including cancer and immunology, by providing a simple yet effective genome editing system. Its simplicity has facilitated large-scale ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

This study designs a DNA logic gate system integrating nucleic acid aptamers, catalytic hairpin assembly (CHA), and CRISPR-Cas12a, pioneering its use for AML antigen detection. The system comprises ...